All Stories

  1. Scaffold and Cell-Based Tissue Engineering Approaches as Alternative Therapy for Blood Vessel Disease
  2. Recent Tissue Engineering Approaches to Mimicking the Extracellular Matrix Structure for Skin Regeneration
  3. The Application of Porous Scaffolds for Cardiovascular Tissues
  4. Recent Developments in Biopolymer-Based Hydrogels for Tissue Engineering Applications
  5. Advances in Cardiac Tissue Engineering
  6. Clinical Application for Tissue Engineering Focused on Materials
  7. Pre-clinical Evolution of a Novel Transcatheter Bioabsorbable ASD/PFO Occluder Device
  8. Heparin-Eluting Tissue-Engineered Bioabsorbable Vascular Grafts
  9. The Real Need for Regenerative Medicine in the Future of Congenital Heart Disease Treatment
  10. The evaluation of a tissue-engineered cardiac patch seeded with hips derived cardiac progenitor cells in a rat left ventricular model
  11. The Evolution of Tissue Engineered Vascular Graft Technologies: From Preclinical Trials to Advancing Patient Care
  12. Tissue engineered vascular grafts for pediatric cardiac surgery
  13. Tissue-engineered Vascular Grafts in Children With Congenital Heart Disease: Intermediate Term Follow-up
  14. Role of Bone Marrow Mononuclear Cell Seeding for Nanofiber Vascular Grafts
  15. Toward a patient-specific tissue engineered vascular graft
  16. Novel application and serial evaluation of tissue-engineered portal vein grafts in a murine model
  17. Tissue-engineered vascular grafts for congenital cardiac disease: Clinical experience and current status
  18. Fast-degrading bioresorbable arterial vascular graft with high cellular infiltration inhibits calcification of the graft
  19. What is the best material for extracardiac Fontan operation?
  20. Tissue Engineering in Vascular Medicine
  21. Preclinical study of patient-specific cell-free nanofiber tissue-engineered vascular grafts using 3-dimensional printing in a sheep model
  22. Tropoelastin inhibits intimal hyperplasia of mouse bioresorbable arterial vascular grafts
  23. TRANSMURAL MACROPHAGE MIGRATION IN TISSUE ENGINEERED VASCULAR GRAFT PROMOTES EXTRACELLULAR MATRIX FORMATION FOR VASCULAR REMODELING MORE THAN HOST CIRCULATING INFLAMMATORY CELL MIGRATION
  24. Nanofiber composites in vascular tissue engineering
  25. Tissue-engineered cardiac patch seeded with human induced pluripotent stem cell derived cardiomyocytes promoted the regeneration of host cardiomyocytes in a rat model
  26. Current Status of Tissue Engineering Heart Valve
  27. Novel Bioresorbable Vascular Graft With Sponge-Type Scaffold as a Small-Diameter Arterial Graft
  28. Deconstructing the Tissue Engineered Vascular Graft: Evaluating Scaffold Pre-Wetting, Conditioned Media Incubation, and Determining the Optimal Mononuclear Cell Source
  29. Tissue-Engineered Small Diameter Arterial Vascular Grafts from Cell-Free Nanofiber PCL/Chitosan Scaffolds in a Sheep Model
  30. Pilot Mouse Study of 1 mm Inner Diameter (ID) Vascular Graft Using Electrospun Poly(ester urea) Nanofibers
  31. tissue engineering
  32. Rational design of an improved tissue-engineered vascular graft: determining the optimal cell dose and incubation time
  33. Neotissue remodeling of tissue-engineered arterial graft
  34. Long-Term Functional Efficacy of a Novel Electrospun Poly(Glycerol Sebacate)-Based Arterial Graft in Mice
  35. Current Status of Tissue Engineered Vascular Graft in Pediatric Cardiac Surgery
  36. Effect of cell seeding on neotissue formation in a tissue engineered trachea
  37. A mouse model of endocardial fibroelastosis
  38. Current Status of Cardiovascular Tissue Engineering
  39. Evaluation of remodeling process in small-diameter cell-free tissue-engineered arterial graft
  40. Potential Molecular Mechanism of Retrograde Aortic Arch Stenosis in the Hybrid Approach to Hypoplastic Left Heart Syndrome
  41. Hemodynamic Characterization of a Mouse Model for Investigating the Cellular and Molecular Mechanisms of Neotissue Formation in Tissue-Engineered Heart Valves
  42. Influence of Posttransplant Lymphoproliferative Disorder on Survival in Children After Heart Transplantation
  43. Cilostazol, Not Aspirin, Prevents Stenosis of Bioresorbable Vascular Grafts in a Venous ModelSignificance
  44. The innate immune system contributes to tissue-engineered vascular graft performance
  45. Comparison of the Biological Equivalence of Two Methods for Isolating Bone Marrow Mononuclear Cells for Fabricating Tissue-Engineered Vascular Grafts
  46. Biomechanical Diversity Despite Mechanobiological Stability in Tissue Engineered Vascular Grafts Two Years Post-Implantation
  47. Development of Small Diameter Nanofiber Tissue Engineered Arterial Grafts
  48. A new tissue-engineered biodegradable surgical patch for high-pressure systems
  49. Contrasting Biofunctionalization Strategies for the Enhanced Endothelialization of Biodegradable Vascular Grafts
  50. TGFβR1 Inhibition Blocks the Formation of Stenosis in Tissue-Engineered Vascular Grafts
  51. First Report of Histological Evaluation of Human Tissue-Engineered Vasculature
  52. Preliminary Experience in the Use of an Extracellular Matrix (CorMatrix) as a Tube Graft: Word of Caution
  53. Comparison of a Closed System to a Standard Open Technique for Preparing Tissue-Engineered Vascular Grafts
  54. Well-organized neointima of large-pore poly(l-lactic acid) vascular graft coated with poly(l-lactic-co-ε-caprolactone) prevents calcific deposition compared to small-pore electrospun poly(l-lactic acid) graft in a mouse aortic implantation model
  55. Development of a Tissue-Engineering Vascular Graft for Use in Congenital Heart Surgery
  56. Targeted imaging of matrix metalloproteinase activity in the evaluation of remodeling tissue-engineered vascular grafts implanted in a growing lamb model
  57. Transplantation of Pulmonary Valve Using a Mouse Model of Heterotopic Heart Transplantation
  58. Implantation of Inferior Vena Cava Interposition Graft in Mouse Model
  59. Vessel Bioengineering
  60. Vessel Regeneration and Bioengineering**Shuhei Tara and Ethan W. Dean contributed equally to the preparation of this manuscript and should be listed as cofirst authors.
  61. Tissue-Engineered Vascular Grafts in Pediatric Cardiovascular Surgery -Past, Now, and Future
  62. Stem cells in tissue-engineered blood vessels for cardiac repair
  63. Contributor contact details
  64. List of Contributors
  65. Tissue Engineering in the Vasculature
  66. Tissue Engineered Small-Diameter Arterial Graft: In Vivo Evaluation of an Electrospun Nanofiber Scaffold
  67. Concise Review: Tissue-Engineered Vascular Grafts for Cardiac Surgery: Past, Present, and Future
  68. Tissue-engineered vascular grafts for use in the treatment of congenital heart disease: from the bench to the clinic and back again
  69. Evaluation of the use of an induced puripotent stem cell sheet for the construction of tissue-engineered vascular grafts
  70. Modified Starnes Procedure in a Neonate With Severe Tricuspid Regurgitation
  71. Characterization of the Natural History of Extracellular Matrix Production in Tissue-Engineered Vascular Grafts during Neovessel Formation
  72. A critical role for macrophages in neovessel formation and the development of stenosis in tissue-engineered vascular grafts
  73. Development of an Operator-Independent Method for Seeding Tissue-Engineered Vascular Grafts
  74. Vascular tissue engineering: Towards the next generation vascular grafts
  75. Restoring Blood Vessels
  76. TISSUE ENGINEERED BLOOD VESSELS: FROM THE BENCH TO THE BEDSIDE AND BACK AGAIN (DEVELOPMENT OF A VASCULAR CONDUIT FOR USE IN CONGENITAL HEART SURGERY)
  77. Embryonic stem cell therapy; A novel cell delivery method
  78. Cell-Seeding Techniques in Vascular Tissue Engineering
  79. Tissue-engineered vascular grafts: does cell seeding matter?
  80. Tissue-engineered vascular grafts transform into mature blood vessels via an inflammation-mediated process of vascular remodeling
  81. Late-term results of tissue-engineered vascular grafts in humans
  82. Characterization of small-diameter electrospun tissue-engineered arterial grafts
  83. Tissue-engineered arterial grafts: long-term results after implantation in a small animal model
  84. 114. Evaluation of the Role of Selective Cell Seeding on Neovessel Formation in Tissue Engineered Vascular Grafts
  85. Tissue-engineered Vascular Grafts Demonstrate Evidence of Growth and Development When Implanted in a Juvenile Animal Model
  86. 7C-3 In Vivo Assessment Method of Tissue-Engineered Vascular Wall Based on Quantitative Elastic Modulus Measurement
  87. Double-outlet right ventricle with left malposition of the great arteries and total anomalous pulmonary venous connection
  88. Clinical Application of Tissue Engineered Vascular Graft Utilizing Biodegradable Polymer Scaffold
  89. Tissue Engineered Heart Valves: Autologous Cell Seeding on Biodegradable Polymer Scaffold
  90. Tissue engineering of autologous aorta using a new biodegradable polymer
  91. Postischemic hyperthermia exacerbates neurologic injury after deep hypothermic circulatory arrest
  92. Creation Of Viable Pulmonary Artery Autografts Through Tissue Engineering
  93. Diastolic ventricular function immediately before and after Fontan procedure
  94. Tissue engineering heart valves: Valve leaflet replacement study in a lamb model
  95. Konno Procedure for Congenital Aortic Stenosis with a Single Coronary Artery from the Left Coronary Sinus
  96. CHAPTER 9. Smart Biomaterials for Cardiovascular Tissue Engineering